Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...

X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as the immune system specialist channels its ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

21:10), and Christ, a Christian's Great High Priest (Heb. 4:14)? In the place where they kill the Burnt Offering shall they kill the Trespass Offering: and the blood thereof shall he sprinkle round ...

Jazmin, a DACA recipient and travel nurse, discusses her fears for her loved ones amid Trump's deportation policies and her ...

Future Markets Research Releases an update following recent developments: Inspira Technologies* (NASDAQ: IINN) has announced ...

Discover how Quietum Plus supports ear health and reduces tinnitus. Read my honest Quietum Plus reviews before you decide.

The following is a summary of “Role of glucocorticoid receptor expression in Chronic Chagas Cardiomyopathy: implications for ...

Chris Latham says he’s got a “burning desire” to coach the Reds and is willing to continue to travel the world, including ...

The research found that heavy drinkers with either diabetes, high blood pressure or a high waist circumference are as much as 2.4 times more likely to develop advanced liver disease.

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...